Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Gastroenterology  |  Immunology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Ulcerative Colitis Clinical Trials

A listing of Ulcerative Colitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (271) clinical trials

A Phase 2, randomized, placebo-controlled, multi-center study to investigate the efficacy and safety of Apremilast (CC-10004) for the treatment of subjects with active ulcerative colitis

Phase

This Ulcerative Colitis Registry study is for Patients with Moderately to Severely Active Ulcerative Colitis and currently taking HUMIRA (Adalimumab) therapy.

Phase N/A

Has your doctor diagnosed you with Ulcerative Colitis? Have you tried different medications but nothing seems to work? If so the Lynn Institute is conducting a medical research study to evaluate an investigational medication for the treatment of Ulcerative Colitis.

Phase N/A

Chevy Chase Clinical Research would like to invite you to participate in a clinical research study evaluating the effectiveness of a medication for Ulcerative Colitis and Crohn’s Disease (IBD). Qualified participants must be: Ages 18 and over Have been previously diagnosed with Ulcerative Colitis and Crohn’s Disease (IBD) All study-related ...

Phase N/A

Multi-Specialty Research Associates of NC is conducting a clinical research trial of an investigational medication for maintenance of ulcerative colitis remission. Qualified participants will receive: Study-related physical exams Study-related lab tests Study medication

Phase N/A

This study is designed to evaluate the effect of treatment with filgotinib on testicular safety in adult males with moderately to severely active Ulcerative Colitis (UC). Stipend range: $75o/v, $100proc For those patients who complete the trial, they will be eligible for the long-term extension study, for up to 195 ...

Phase

This is a phase 2a, randomized, double-blind, placebo-controlled, parallel group, multicenter study in subjects with active UC and a non-remission response to infliximab.   There will be up to 13 study visits, across the 12 weeks of treatment, along with 2 follow-up visits, at Weeks 16 and 22. Ideal patients ...

Phase

This is a phase 4, open-label, multicenter study to investigate the efficacy and safety of dose optimization of vedolizumab IV, compared with standard dosing of vedolizumab IV, over a 30-week treatment period. This study will enroll adult subjects with moderately to severely active ulcerative colitis (UC) who are eligible for ...

Phase

This study is designed to evaluate the effect of treatment with filgotinib on the induction and maintenance of remission in subjects with moderately to severely active Ulcerative Colitis (UC). For those patients who complete the trial, they will be eligible for the long-term extension study, for up to 144 additional ...

Phase

The trial is composed of 2 periods: Induction and Maintenance. Patients will be entered into the trial in 2 separate cohorts through the Induction Period (10 weeks) and those patients in clinical response at the end of the Induction Period will proceed through to the Maintenance Period. Participation in these ...

Phase